<DOC>
	<DOCNO>NCT02574520</DOCNO>
	<brief_summary>This research study SABER® -Bupivacaine , experimental medication design relieve pain 3 day surgery . Given surgeon end surgery , SABER® - Bupivacaine delivers locally-acting pain reliever directly surgical wound . The purpose study measure well work reduce pain laparoscopic cholecystectomy ( surgery remove gall bladder ) investigate safety SABER®-Bupivacaine ( side effect ) .</brief_summary>
	<brief_title>Trial Extended Release Bupivacaine Pain Relief After Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Patients schedule elective outpatient laparoscopic cholecystectomy use conventional 4port laparoscopic procedure . Must able willing provide write informed consent , complete trialrelated procedure , communicate trial staff . Males females 18 year age old . ASA Class I , II , III . Patients childbearing potential must agree use medically acceptable method contraception prevent pregnancy duration participation trial . Must live close enough investigative site attend four schedule followup clinic visit . Pregnant nursing female . Patients absolute relative contraindication laparoscopic cholecystectomy . Patients prior midline abdominal surgery risk adhesion may complicate laparoscopic cholecystectomy and/or accurate pain assessment . Patients require emergency surgery urgent surgery ( few 5 day screen surgery ) . Patients preplanned overnight stay preplanned hospital admission . Patients schedule single incision , mini trocars , natural orifice transluminal endoscopic surgery ( NOTES ) , robotic laparoscopic procedure , procedure ( cholangiograms minimal adhesiolysis ) addition laparoscopic cholecystectomy . Patients know hypersensitivity amide local anesthetic bupivacaine . Patients acute pain due cholecystitis . Patients history chronic pain unrelated gallbladder disease . Patients ongoing depression psychosis . Patients undergoing longterm treatment opioids analgesic , include acetaminophen , NSAIDs , anticonvulsant ( gabapentin pregabalin ) , antidepressant ( SSRIs , SNRIs , tricyclic ) , include daily lowdose aspirin . Patients treat chronically systemic corticosteroid require perioperative corticosteroid adrenal insufficiency ( inhalational topical corticosteroid permit ) . Patients may unsuitable opioid administration ( sensitivity [ e.g. , history severe nausea vomit ] hypersensitivity , know history abuse addiction , unwillingness take prescribe rescue opioids ) . Use anticoagulant antiplatelet drug ( exception low dose aspirin ) 1 week prior surgery . Patients incapable operate electronic diary . Patients participate trial investigational drug device concurrently less 30 day prior surgery trial . Patients , Investigator 's opinion , participate trial may capable follow trial procedure reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Post-operative pain</keyword>
	<keyword>opioid</keyword>
	<keyword>opioid reduction</keyword>
	<keyword>laparoscopic cholecystectomy</keyword>
	<keyword>laparoscopic surgery</keyword>
	<keyword>bupivacaine</keyword>
	<keyword>extend release</keyword>
	<keyword>locally act analgesic</keyword>
</DOC>